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COMPARISON OF LENGTH OF ANESTHESIA USING THE VASOCONSTRI~ORS, 
EPINEPHRINE AND PHENYLEPHRINE, WITH PROCAINE, CARBOCAINE~* 
AND LIDOCAINE 
I. INTRODUCTION 
A. Background of local anesthetics. 
In a list of medical discoveries which have greatly influenced 
the course of medical practice one would surely have to include 
the discovery of local anesthetics. 
Niemann was the first to observe in 1860 that an alkaloid, 
cocaine, when placed on the tongue, caused a sensation of 
numbness. Although other pioneers are mentioned in connection 
with experiments with cocaine, it remained for Sigmund Freud and 
Karl Koller in 1884 to develop the practical application of cocaine 
as a local anesthetic to medical practice. A short time later 
Halstead in the United States started investigations which led 
to the discovery of nerve blocks. In 1905 Einhorn introduced 
procaine, a synthetic local anesthetic which displayed less 
toxicity than cocaine and did not promote addiction. Since 
then, numerous local anesthetics have been synthesized, dis-
playing various degrees of anesthesia, toxicity and duration 
of action. 
Many of the Common local anesthetics are esters of amino 
alcohols and aminobenzoic acid. When injected they are in 
an ionized form. In this form they are transported to the 
nerve tissue where the alkaline environment changes the drug 





to an un-ionized form. 2 Although the mechanism of action of 
local anesthetics isn't completely understood it is thought 
that this un-ionized form depolarizes the nerve membrane so that 
conduction is interrupted. Thus, poor anesthesia is obtained in 
an infected area because of the acidic environment which keeps 
the anesthetic ionized. Pain disappears first, then cold, 
warmth, touch and deep pressure. 
It has been noted that the time required for induction of a 
blockage by a particular drug varies inversely with the con-
centration of the drug and directly with the square of the 
radius of the nerve. However, duration of anesthesia is 
usually affected by concentration also, with the higher con-
centrations lasting longer than the very dilute solutions. 
Above certain concentrations (which are actually quite dilute 
solutions) no practical increase in anesthesia is obtained but 
increased toxicity with danger to the patient is found. 
Most local anesthetics do have certain toxic actions which 
can produce very serious effects on the patient when used 
incorrectly. Local toxicity is demonstrated by the damage to 
tissue due to the effects of the drug at the site of injection. 
Systemic toxicity is manifest by reactions which are usually 
due to an increased blood concentration of the anesthetic. 
This can be caused by giving too great a quantity of anesthetic, 
too rapid absorption, giving the anesthetic intravascularly, or 
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insufficient destruction of the anesthetic. A few reactions 
have been explained on a hypersensitivity and anaphylactoid 
basis. 
One means of better controlling absorption of local anesthetics 
has been the addition of vasoconstrictor substances to the 
anesthetic. This causes local vasoconstriction of the vessels, 
slowing down spread and absorption of the anesthetic. It permits 
the use of less anesthetic and makes possible more intense and 
more prolonged anesthesia without an increase in quantity of 
anesthetic. This results in a decrease in severity and frequency 
of toxic symptoms due to absorbed anesthetic agents. 
Campbell and Adriani4 found that using 1:100,000 epinephrine 
with procaine decreased certain signs of toxicity from the pro-
caine by 30%. The optimal concentration of epinephrine to use 
with local anesthetics was studied by Keesling and Hinds14 who 
noted that a solution of 1/250,000 epinephrine was as effective 
in increasing depth and duration of anesthesia as 1/50,000 or 
1/100,000 concentrations. (Lidocaine was the only anesthetic 
used) • 
Another advantage to a vasopressor in a local anesthetic is 
that it decreases hemorrhage at the site of an operation or 
laceration. 
Disadvantages of using a vasoconstrictor could probably be 
listed as: 
1. Danger to tissues if injected into an area with a 
blood supply consisting of end arteries. 
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2. Danger of too much epinephrine being mixed with 
the anesthetic and causing toxic symptoms. 
3. Inconvenience of adding a second drug to the local 
anesthetic being used. 
4. Contraindications: Hypertension, severe arterio-
sclerosis, pheochromocytoma, and thyrotoxicosis. 
B. Drug Description. 
1. Procaine. 
Of the three local anesthetic agents used in this study, 
procaine is the most common. It is an amino ester made from 
an amino alcohol and para-amino benzoic acid and is soluble 
in water to the extent of 1 gram in 1 cc. of water. It is 
still probably the most widely used of currently available 
local anesthetics. Procaine produces fairly good anesthesia 
and has little toxicity except in larger doses. It is not 
very effective as a topical anesthetic as it is poorly ab-
sorbed from the mucous membranes. Procaine is used as the 
standard for toxicity and potency in comparing injectable 
anesthetics. A rate of about 1 gram per hour appears to be 
tolerated by man. 
Usually 1 or 2 per cent solutions are used but 4 per cent 
is used for some dental extractions. 
2. Lidocaine. 
Lidocaine (Xylocain~* was synthesized by Loefgren in 1943 
and is readily water soluble and stable. It was derived from 
* Xylocaine is the trade name used by Astra Pharmaceutical Products, 
Inc., for lidocaine. 
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acetanilide and is somewhat greater in toxicity and potency 
than procaine. Maximum doses per injection is generally 
thought today as one half of that for procaine, or 500 mg. 
It is effective topically on mucous membranes whereas 
procaine is not. Lidocaine is usually used in one half to 
two per cent solutions for infiltration. 
3. Carbocaine. 
Carbocaine is a comparatively new local anesthetic syn-
thesized in 1956. It has a greater potency and it seems to 
be less irritating than procaine. Luduena16 and his group 
found that carbocaine had twice the duration of action of 
lidocaine. He also found that carbocaine injected into mice 
was twice as toxic as procaine but was less toxic than 
lidocaine. Maximum dose per injection in man is presently 
recommended at 500-750 mg. 
4. Epinephrine (Adrenalin~ Suparareni~* 
This is a substance which is produced in the body by the 
adrenal medulla. It is also synthetically made in the laboratory. 
It's action is adrenergic: constriction of most arteries and 
veins, constriction of mucous membranes, cardio acceleration, 
relaxed bronchi, etc. 
Administration is usually parenteral as there is poor re-
sponse when administered orally. 
Inactivation is usually quite r~pid and is thought to be 
accomplished through several enzyme systems capable of 
* Adrenaline is Parke Davis trade name and Suprarenin is the 
Winthrop trade name for epinephrine solutions. 
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inactivating the dehydroxyphenyl adrenergic amines. 
This is a very potent drug and usual therapeutic doses 
will produce minor toxic symptoms (anxiety, tremor, headache, 
palpitations). These do not usually last long and are not 
thought to be dangerous. Overdosage produces toxic effects 
which can be fatal, however. These include cerebrovascular 
hemorrhage produced from the elevated arterial pressure, 
pulmonary edema from pulmonary arterial hypertension, and 
ventricular hyperirritability. Dose for any parenteral 
route other than intravenous is 1 mg. or less. With local 
anesthetics the concentration of epinephrine is usually 
1:100,000 or 1:200,000, although in dental practice a con-
centration of 1:60,000 is often used. 
5. Phenylephrine (Neo-Synepbrin~* 
This vasopressor drug is less potent than levarterenal and 
has a little longer duration of action. Parenteral adminis-
tration in humans produces peripheral vasoconstriction, 
increased arterial pressure, and reflex bradycardia. It does 
not stimulate cardiac tissue to the degree that epinephrine 
does nor does it produce central stimulation. 
Doses often advocated are: 0.5 mg. intravenously, 5 mg. 
subcutaneously, or 250 mg. orally. In local anesthetics it 
is used in concentrations of 1:2500 to 1:54,000. 
* Neo-Synephrine is the trade name of the Winthrop Laboratories 
for phenylephrine. 
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II. PURPOSES OF STUDY 
The effects of local anesthetics in inhibiting pain has been 
studied on nerve specimens, animals and man. Although experiments 
on laboratory animals and specimens usually produce more accurate 
values and afford more reliable duplication of results, the findings 
do not necessarily apply to man. Pain is a subjective phenomenon 
which is very difficult to study in animals. Therefore, any final 
test of pain inhibiting drug which is to be used primarily on 
humans must ultimately be tested on humans. 
The purpose of this study was first to compare the length of 
anesthesia of three local anesthetics; procaine, lidocaine and 
carbocaine. The second purpose was to compare the three local 
anesthetics without a vasoconstrictor to similar solutions with 
(a) epinephrine and (b) phenylephrine added. A third comparison 
to be noted is what differences, if any, exist between local 
anesthetics with epinephrine added and anesthetics with phenylephrine 
added. Interest here is focused particularly on the use of phenyl-
ephrine, as this is not commonly used with local anesthetics. 
Epinephrine is the main vasoconstrictor used with local anesthetics. 
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III. METHOD 
Early in the study, it was hoped that we could use a small 
electric nerve stimulator with a method of injecting materials 
around the nerve which was to be blocked. However, this 
necessitated 10 different injections into the area around the 
same nerve, each of which required considerable time as well as 
a danger of injury to the nerve with so many injections. 
Therefore, we decided to use intracutaneous injections into 
the anterior surface of the forearms. 
A. Test substances (10 different items) 
1. Procaine, lidocaine, carbocaine, 1% solutions. 
2. Procaine, lidocaine, carbocaine, 1% solutions 
with 1:200,000 epinephrine added. 
3. Procaine, lidocaine, carbocaine, 1% solutions 
with 1:25,000 phenylephrine added. 
4. Saline, normal. 
These test drugs were prepared by Dr. J. Jones and placed 
in bottles which had only an alphabetic letter on them. The 
exact contents of each bottle was known only to Dr. Jones 
until the study was completed. The pH of each test drug 
was determined before and after testing with little change 
noted. 
B. Procedure 
One milliliter from each bottle was injected, subcutaneously, 
using 25 gauge needles, into a cleaned area on the anterior 
forearms of each volunteer, care being taken that the injection 
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sites were properly spaced to avoid overlapping of anesthesi~. 
Each wheal was marked with the letter indicating which test 
drug had been injected. The same drugs were not used in 
exactly the same areas on each volunteer but were rotated 
around the various areas. 
c. Testing the degree of anesthesia. 
Each volunteer was given essentially the same amount of 
information about the study and instructions they were to 
follow. None of them knew what were in the test bottles. 
Each volunteer was asked to check the various test sites every 
5 minutes in order to ascertain when the anesthesia wore off. 
They were instructed to use 25 gauge needles in testing for 
loss of pain and to use approximately the same amount of 
pressure on each test site in determining anesthesia. Mimeo-
graphed sheets were made and on which the volunteers marked 
the (a) time when the injection was made; (b) time of onset 
of anesthesia; (c) time when some pain first came back into 
the area and (d) that time when pain sensation had completely 
returned. 
Any toxic signs or symptoms, whether local or of a more 
systemic nature, were to be noted. 
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IV. RESULTS AND BISCUSSION 
Anesthesia was almost invariably complete immediately after the 
injection of one milliliter of the test drug. The area of anesthesia 
was usually limited to the area of the original wheal formation. 
When 2 milliliters of test drug was used, considerable over-
lapping of anesthesia was noted, particularly distal to the wheal. 
Also greater burning was noted upon injection of the drug. 
Therefore, 1 milliliter was used throughout the study. 
The length of time from the onset of anesthesia until the first 
detectable pain sensation was noted in each case and an average 
length of anesthesia in minutes determined for each test drug 
(Table I). When these are compared with the average length of 
anesthesia from onset until complete return of pain sensation to 
pin prick (Table 2), it is noted that most volunteers detected 
some return of pain from 20 to 60 minutes before pain sensation 
had completely returned. This is indicative of the diffusion of 
the anesthetic into the tissues and blood stream and gradual 
return of normal function to the nervous tissue involved. 
Table 2 gives the range of values as well as the mean anesthesia 
time for each test drug. These values are the number of minutes 
from onset of anesthesia until complete return of pain sensation 
to pin prick. 
A comparison of the average length of anesthesia of procaine, 
carbocaine, and lidocaine show that anesthesia lasted about 66% 
longer in the cases of lidocaine and carbocaine over procaine. 
- 10 -
However the range of values was considerably wider with lidocaine 
and carbocaine. This does not agree with Luduena16 and his group 
who found that carbocaine had twice the duration of action of 
lidocaine. Lidocaine is thought to be about twice as potent as 
procaine. Our results show procaine with a mean length of anesthesia 
of 61.5 minutes and lidocaine with a mean length of anesthesia of 
102.6 minutes. 
When epinephrine was added to carbocaine a 50% increase in the 
average length of anesthesia time was noted. In comparing carbo-
caine with epinephrine and carbocaine without epinephrine, we have 
a standard error of the difference between the two means of 17.4 
minutes and a relative deviate of 2.76. This shows we are out on 
the far sides of our distribution curve a distance of 2.76 standard 
errors. In a normal distribution 99% of the values lie within 
2.6 standard errors of the mean. This would give us a proba-
bility (p) of less than 0.01, in which case we can conclude that 
something other than chance caused the difference in our two 
samples. In this case the presence of epinephrine is the one known 
differing factor and we can conclude that it probably caused the 
increased length of anesthesia time. 
Procaine with epinephrine added showed a mean anesthesia time 
increase from 61.5 minutes to 214.0 minutes. Comparing the 
procaine with epinephrine (test item) with the procaine without 
epinephrine (control sample) we find that our relative deviate 
is 4.8 which statistically is very significant. (When out 3 
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standard errors from the mean, 99.73% of the values are included). 
Here also we can conclude that random sampling or chance couldn1t 
have caused this large a variation between the two test items. 
Lidocaine with epinephrine showed about 100% increase in mean 
anesthesia time. However, there was a wide dispersion of the 
values so that there was a standard error of the mean of 42 min-
utes with a standard error of the difference between the 2 means 
(lidocaine with and without epinephrine) of 46.0 minutes. The 
relative deviate was 2.3 which would give a probability of about 
0.03. (When out two standard errors you are at the 95 percentile 
and have a probability of 0.05 which has borderline significance). 
A probability of 0.03 is statistically significant and we would 
conclude that the ~pinephrine added to the lidocaine probably 
caused the increase in anesthesia time. 
When phenylephrine was added to carbocaine the mean anesthesia 
time increased from 103.5 minutes to 238.7 minutes. The relative 
deviate was 6.5 which is very significant statistically. 
Procaine with phenylephrine added increased very little in 
mean anesthesia time (61.5 to 76.7). In comparing procaine with 
and without phenylephrine the relative deviate was 1.36. This 
would be about the 75th percentile. Thus, in future samples of 
these test items there would be 25% of them with differences as 
great as or greater than those in our actual study and could be 
due to chance. Therefore, the small increase in mean anesthesia 
time observed with the phenylephrine added to the procaine is not 
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statistically significant and could be due to chance. 
Lidocaine increased in mean anesthesia time from 102.6 minutes 
to 220.4 minutes with phenylephrine added. It had a relative 
deviate of 4.03 which indicates that this difference in anesthesia 
time between the lidocaine containing phenylephrine and the lido-
caine without phenylephrine is significant and is probably due to 
the phenylephrine and not due to chance. 
In comparing the two vasoconstrictors used in this study, it 
can be seen that when added to lidocaine the mean anesthesia 
times are about the same but the range of values of the lidocaine 
and epinephrine causes it to have less statistical significance 
than the lidocaine with phenylephrine added. 
The large difference in mean anesthesia time between the two 
vasoconstrictors added to procaine has already been mentioned. 
The lack of re?ponse of phenylephrine with procaine will have to 
remain unexplained for the present. 
Carbocaine with phenylephrine showed a significantly longer 
mean anesthesia time than when epinephrine was added. FUrther 
studies involving various concentrations of these two vaso-
constrictors as well as different concentrations of the anesthetics 
would help in explaining differences noted in mean anesthesia time. 
No similar studies using phenylephrine with local anesthetics were 
found in order to compare results. One volunteer had anesthesia 
of the area in which normal saline was injected. This could have 
been caused by injecting the saline around the cutaneous nerve 
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supplying this area with enough pressure to cause a disruption of 
nerve impulses. His anesthesia lasted for 101 minutes. When 
this test was repeated a few weeks later he experienced no 
anesthesia. 
No systemic reaction to the test items were noted. The only 
local "reactions" noted were small red papules on certain wheals 
of some volunteers. No consistency involving certain test drugs 
causing these small red papules was noted. 
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V. CONCLUSIONS 
Lidocaine and carbocaine exhibited about a 70% greater mean 
anesthesia time than procaine. These two anesthetics (lidocaine 
and carbocaine) had mean anesthesia times which were within one 
minute of each other indicating similar potency at these con-
centrations and for subcutaneous injections. 
When epinephrine was added to the local anesthetics, they all 
had significant increases in duration of anesthesia, although 
larger increases were noted with lidocaine and procaine, the 
latter not being statistically as significant due to the wide 
range of the observations. 
Phenylephrine is not considered as potent a vasoconstrictor 
as epinephrine but significant increases in duration of anesthesia 
were noted when phenylephrine was added to carbocaine and lidocaine. 
The mean anesthesia time of the carbocaine and phenylephrine was 
about 50% more than when epinephrine was added to the carbocaine. 
The reason for phenylephrine producing these results with carbo-
caine but causing little increase in duration of anesthesia when 
added to procaine remains unexplained. 
From this study we can conclude that phenylephrine added to 
carbocaine or lidocaine (in the amounts used) does as well in 
prolonging local anesthesia time as when epinephrine is added as 
the vasoconstrictor. It also can be concluded that little, if 
any, change is noted in duration of anesthesia when phenylephrine 
is added to procaine. 
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The use of epinephrine, of necessity, must be limited in patients 
with hypertension, arteriosclerosis, cardiac arrhythmias, angina, 
coronary thrombosis and diseases of hypermetabolism such as 
thyrotoxicosis. The fact that phenylephrine prolonged the anesthesia 
time as long as epinephrine indicates that the local anesthetic is 
not absorbed any faster with the former vasopressor as with the 
latter. This would indicate that phenylephrine should be used in 
place of epinephrine in patients with the before mentioned disease 
states. 
Further investigations should include larger populations as 
well as using different and varied concentrations of the vaso-
constrictors and the anesthetics. As was stated earlier, pain is 
a subjective finding, the detection and degree of which is difficult 
to determine and evaluate. If changes in pain sensation are care-
fully noted and recorded however, statistically significant data 
can be obtained. 
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SUMMARY 
It has been known for many years that vasoconstrictors prolong 
the duration of anesthesia when added to local anesthetics. 
However, there are few studies involving specific anesthetics with 
specific vasoconstrictors and their effect on humans. Epinephrine 
is the vasoconstrictor usually used with local anesthetics. Other 
vasoconstrictors are rarely used for this purpose. 
The object of this study was to find out what differences 
existed between three local anesthetics, procaine, lidocaine and 
carbocaine as to duration of anesthesia, both with and without 
vasoconstrictors added. Using two different vasoconstrictors, 
epinephrine and phenylephrine, a further comparison could then 
be drawn between these two for effectiveness in prolonging 
anesthesia. 
The method consisted of intracutaneous injections in the forearms 
of ten volunteers who then measured degree and length of anesthesia 
by checking for pain by pin prick. Ten injections of 1 cc. each 
were made on each volunteer; a 1% solution of each anesthetic 
(procaine, lidocaine and carbocaine), a 1% solution of each 
anesthetic with 1/200,000 epinephrine added, 1% solutions of each 
anesthetic with 1/25,000 phenylephrine added, and an injection 
consisting of 1 cc. of normal saline. 
Lidocaine (102.6 minutes) and carbocaine (103.5 minutes) had 
about twice the mean anesthesia time as procaine. 
When epinephrine was added, an increase of mean anesthesia 
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time ranged from a 50% increase for carbocaine to a 250% increase 
for procaine. Lidocaine with epinephrine had a marked increase 
in mean anesthesia time but the values fell over such a wide 
range that its statistical significance was not as great as when 
procaine and carbocaine solutions with epinephrine were compared 
to solutions without epinephrine. 
Procaine with phenylephrine showed little increase in mean 
anesthesia time. Lidocaine and carbocaine however, showed in-
creases in duration of anesthesia time as great or greater than 
when epinephrine was used. These were also statistically significant. 
This study indicates that phenylephrine, when used with lidocaine 
or carbocaine and in the concentrations used in this study, would 
perform as well as epinephrine and would be particularly useful 
with those patients who have hypertension, thyrotoxicosis, arterio-
sclerosis and other disease states in which the use of epinephrine 
is rather limited. 
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standard Standard Standard Relative 
Error of the E:r:nr of the Mean Deviation Dl erence Deviate Mean Between Means 
Procaine 61.5 20.5 6.5 
Procaine with 31.3 4.8 
epinephrine 214.0 96.4 31.0 
Lidocaine 102.6 58.4 18.7 
Lidocaine with 46.0 2.3 
epinephrine 209.8 130.3 41.9 
Carbocaine 103.5 37.1 12.0 
Carbocaine with 
17.4 2.76 
epinephrine 152.0 40.1 12.9 
Procaine 61.5 20.5 6.5 
Procaine with 11.0 1.36 
phenylephrine 76.7 27.4 8.7 
Lidocaine 102.6 58.4 18.7 
29.0 4.03 
Lidocaine with 
phenylephrine 220.4 69.3 22.3 
Carbocaine 103.5 37.1 12.0 
21.3 6.5 
Carbocaine with 
phenylephrine 238.7 56.0 18.1 
TABLE 3. Statistical Data (mean, standard deviation, standard error of the 
mean, standard error of the difference between two means are all 
given in minutes). 
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